This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
Cervical cancer remains one of the few cancers that can potentially be eliminated through human papillomavirus (HPV) vaccination, regular screening and timely treatment of precancerous changes. Despite the availability of effective prevention and treatment measures, global deaths from cervical cancer are projected to increase by nearly 40% by 2050, according to a study involving researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and the Institute for Health Metrics and Evaluation (IHME) at the University of Washington.
Published in Nature Medicine, the study was conducted as part of the Global Burden of Disease (GBD) 2023 Study and analyzed cervical cancer incidence, mortality and health loss across 204 countries and territories from 1990 to 2023, with forecasts to 2050. Researchers estimated that 887,000 women developed cervical cancer and 369,000 died from the disease worldwide in 2023.
Although the global rates of women developing and dying from cervical cancer are projected to decline after accounting for differences in demographic structure, the total number of cases and deaths is expected to rise as populations grow and age.
3% to 522,000, compared with 2024. These findings highlight the need to strengthen prevention, screening and treatment services to meet growing health care demands.
Source link







